• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 1.50% Nasdaq down 2.41%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 1.50% Nasdaq down 2.41%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    No such ticker symbol: OCHT.PKTry Symbol Lookup
    No such ticker symbol: EFOT.PKTry Symbol Lookup
    No such ticker symbol: BII.LTry Symbol Lookup
    No such ticker symbol: IASCA.PKTry Symbol Lookup
    Jun 27 0.1153 -0.0002 -0.17% 0.111 0.1219 585,562 571,651 28.6173M Sparkline Chart Chart, News, Stats, Board
    {"s" : "heb","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Monday June 20, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online04:17pm EDT
    Friday June 10, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year EDGAR Online04:18pm EDT
    Wednesday June 8, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online04:23pm EDT
    Hemispherx Biopharma Enters into Settlement Agreements Dismissing All Pending Shareholder Derivative Litigation, Resolving Disputes with Insurance Carriers, and Obtaining Commitments of $3.5 Million in Payments to Company GlobeNewswire11:53am EDT
    Tuesday June 7, 2016
    Hemispherx gets IP rights from the CEO it fired at American City Business Journals11:40am EDT
    Hemispherx Biopharma: Dr. William M. Mitchell Publishes Article Titled, “Efficacy of Rintatolimod in the Treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)” in Expert Review of Clinical Pharmacology GlobeNewswire08:30am EDT
    Monday June 6, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events EDGAR Online05:04pm EDT
    Hemispherx Biopharma Obtains a Comprehensive Carter Omnibus Assignment of Intellectual Property GlobeNewswire08:30am EDT
    Tuesday May 31, 2016
    Early Morning Technical Highlights on Biotech Stocks Company Spotlight09:15am EDT
    Hemispherx Biopharma Renews Sales, Marketing, Distribution and Supply Agreement with GP Pharm GlobeNewswire08:30am EDT
    Wednesday May 25, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events EDGAR Online10:14am EDT
    Tuesday May 24, 2016
    HEMISPHERX BIOPHARMA INC Financials EDGAR Online Financials01:04pm EDT
    Monday May 23, 2016
    Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for Rintatolimod in Europe GlobeNewswire08:30am EDT
    Monday May 16, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online06:12pm EDT
    Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2016 GlobeNewswire05:09pm EDT
    Thursday May 12, 2016
    Hemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on May 17, 2016 GlobeNewswire08:30am EDT
    Wednesday April 20, 2016
    Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for Alferon® and Ampligen® GlobeNewswire08:30am EDT
    Tuesday April 5, 2016
    Hemispherx signs deal with Saudi Arabian drug company at American City Business Journals10:15am EDT
    Monday April 4, 2016
    Hemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution, and Supply Agreement with Saudi Arabia’s Premier Pharma Company in Fight Against the Deadly MERS Disease GlobeNewswire08:30am EDT
    Friday April 1, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online03:21pm EDT
    Wednesday March 30, 2016
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, EDGAR Online06:24am EDT
    Tuesday March 29, 2016
    Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2015 GlobeNewswire05:41pm EDT